New Methods Of Treatment Of Autoimmune Diseases – Part 3 of 3
Patients reported mild and moderate string effects during their treatments. Nearly all these problems, except for a metallic taste in the mouth, were judged to be unrelated to the study treatment. The six patients with mild disease activity showed no new symptoms or worsening in their conditions three months after the infusions. What’s more, MRI scans showed no unexplored areas of inflammation after their treatments.
Two of the three patients with more active disease had worsening symptoms within two weeks of treatment. Those symptoms cleared up with steroid treatments. MRI scans showed all three patients developed additional lesions that indicated a worsening of inflammation.
None of the patients lost neurologic mission during the six months they were followed after their treatments. “Whether it’s going to have a longstanding effect, or an effect in locking down the disease symptoms in MS patients, is going to take a phase 2 or side 3 trial,” said Miller, who disclosed that he shares rights to a patent on the technique. The study was supported by private grants from foundations in Germany and the United States, and by funding from the German government.